Syndecan-1 as specific cerebrospinal fluid biomarker of multiple sclerosis
Geoffrey Hinsinger, Lucile Du Trieu de Terdonck, Serge Urbach, Nicolas Salvetat, Manon Rival, Manon Galoppin, Chantal Ripoll, Renaud Cezar, Sabine Laurent‐Chabalier, Christophe Dematteï, Hanane Agherbi, Giovanni Castelnovo, Sylvain Lehmann, Valérie Rigau, Philippe Marin, Éric Thouvenot
The paper identifies Syndecan-1 as a specific cerebrospinal fluid biomarker for multiple sclerosis, improving diagnostic and prognostic accuracy compared to existing markers.
bioRxiv · May 10, 2023 · PreprintNeuroscience